Reslizumab for Inadequately Controlled Asthma With Elevated Blood Eosinophil LevelsLeif Bjermer, Matthew Germinaro, Catherine Lemière et al.|CHEST Journal|2016Cited by 426
Prevention of Cardiovascular and Other Systemic Adverse Outcomes in Patients with Asthma Treated with BiologicsMohsen Sadatsafavi, Κonstantinos Κostikas, John Busby et al.|American Journal of Respiratory and Critical Care Medicine|2025Cited by 17
Impact of Biologic Initiation on New-onset of Corticosteroid-related Adverse Effects in Patients With Severe AsthmaDavid Price, T.N. Tran, B. Emmanuel et al.|American Journal of Respiratory and Critical Care Medicine|2025Cited by 0
Reply to Liu et al., Zhou et al., and Dong et al.Mohsen Sadatsafavi, Charlotte Suppli Ulrik, Trung N. Tran et al.|American Journal of Respiratory and Critical Care Medicine|2025Cited by 0